万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://academic.oup.com/g3journal
3、投稿网址：https://g3.msubmit.net/
4、官网邮箱：g3-gsa@thegsajournals.org
5、期刊刊期：月刊，一年出版十二期。
2021年4月29日星期四
投稿须知【官网信息】
Instructions to Authors
About the Journal
Editorial Policies
Data Policy
Submission
Article Types
Manuscript Preparation: Format, Structure, and Style
License to Publish
Manuscript Charges
Advance Articles
About the Journal
G3 is a peer-reviewed journal that publishes 12 issues per year online.
Papers in G3 may have associated charges. Please refer to the Charges section below.
Once a paper is accepted and final files provided, G3 will publish a pre-copyedited, pre-proofed version of the paper online within 1 week. This is replaced by a copyedited, proofed version of the paper as soon as it is ready.
Please read these instructions carefully and follow them closely. The Editors may return manuscripts that do not follow these instructions.
Scope of the Journal
G3, published by the Genetics Society of America, meets the critical and growing need of the genetics community for rapid review and publication of important results in all areas of genetics. G3 offers the opportunity to publish the puzzling finding or to present unpublished results that may not have been submitted for review and publication due to a perceived lack of a potential high-impact finding.
G3 is a peer-reviewed, peer-edited journal. All editorial decisions are made through collaboration of at least two peer-editors.
Criteria for Publication
the experiments and other analyses are of high-quality and are clearly described and reasonably interpreted;
the study describes information (e.g. large‐scale datasets; sequence or QTL information), reagents or new resources (e.g. results of a mutant screen; mutant; collections for functional genomic experiments) or tools/methodologies (e.g. statistical/computational methods) whose availability would be valuable for genetics and genomics investigators;
the results are original and adhere to all community standards for data availability and format (note: in certain cases we will specify required data formats in instructions to authors);
the results presented provide strong support for the conclusions reached.
Editorial Policies
For full details of Oxford University Press’s editorial policies, please see Publication Ethics.
Authorship
Authors are those who contributed substantially to the research documented in the paper and share responsibility for the resulting article. The names of these researchers should appear in the byline. Those who assisted peripherally but are not authors should be recognized in the Acknowledgments. All authors are responsible for the article's content. A Co-corresponding Author(s) can be designated, but the Corresponding Author has the authority to act on behalf of all authors. Authorship data entered during manuscript submission appears in the published-ahead-of-print version, so be sure to complete all fields. To avoid production delays post-acceptance, please be sure that the author list is final and accurate at time of first submission. If there are changes post-acceptance please contact the Editorial Office to discuss the authorship changes. G3 follows COPE (Committee on Publication Ethics) guidelines and will obtain approval from the editor and all authors for authorship changes.
Peer Review
This journal uses single blind peer review.
Portable Peer Review
If your manuscript was previously peer reviewed prior to submission at G3 and you are interested in including and responding to those reviews as part of your G3 submission, please 1) contact the editorial office at g3-gsa@thegsajournals.org and 2) indicate such in your cover letter. The editorial office will contact the previous editorial office to request the decision letter, reviews, and if possible, reviewer identities. We will then provide this information to the editors handling your manuscript to aid in the decision-making process. Editors may choose to have the manuscript sent for further review either by the original reviewers or new reviewers. In that case, you will be given the opportunity to decline additional review and withdraw your submission.
Editor and Reviewer Suggestions and Exclusions
Authors are encouraged to suggest experts who could provide an unbiased review of their work. Please do not list close associates, collaborators, family members, or researchers who are at your institution. If authors wish to exclude editors or reviewers from handling their work, they should provide a brief (2-4 sentence) statement explaining the reason for exclusion in the submission form. We strive to honor requests.
Preprint Policy
Authors retain the right to make an Author’s Original Version (preprint) available through various channels, and this does not prevent submission to the journal. For further information see our Online Licensing, Copyright and Permissions policies. If accepted, the authors are required to update the status of any preprint, including your published paper’s DOI, as described on our Author Self-Archiving policy page.
Self-Archiving Policy
You may self-archive versions of your work on your own webpages, on institutional webpages, and in other repositories. If you want more information about the reuse rights you retain if you publish with us, please visit our Author Self Archiving Policy page.
Conflict of Interest
When submitting a paper, you and your co-authors must declare any potential conflicts of interest. You must do this by providing the relevant details on our online submission site and by including a Conflict of Interest statement in your submitted manuscript. For a detailed definition of conflicts of interests, please see Conflict of interest.
Please also describe any affiliations that may present a conflict of interest in either the choice of Senior Editors, Associate Editors, or reviewers. This information will remain confidential.
Informed Consent/Privacy and Confidentiality
Authors must ensure that these guidelines are followed, as recommended directly by the International Committee of Medical Journal Editors in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org:
"Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Patient consent should be written and archived with the journal, the authors, or both, as dictated by local regulations or laws."
"Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained...If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance, and editors should so note, that such alterations do not distort scientific meaning."
For G3, when informed consent is deemed necessary and has been obtained, please indicate in the Methods section the manner in which that informed consent was obtained. Editors may ask authors to provide documentation of the formal review and recommendation from the institutional review board or ethics committee associated with the research. See also Human Subject Data in these instructions.
Protection of Human and Animal Subjects
Authors must ensure that these guidelines are followed, as recommended directly by the International Committee of Medical Journal Editors in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org:
"When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed."
Scientific Misconduct
GENETICS and G3: Genes|Genomes|Genetics take allegations of scientific misconduct seriously and investigate each on a case by case basis. We consult the guidelines provided by COPE (Committee on Publication Ethics), International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME) during this process.
GENETICS and G3 reserve the right to contact the authors’ institutions, funders, or regulatory bodies if needed. Should the allegations occur prior to publication of the article, we reserve the right to halt the peer review and publication process until the investigation is complete. In the case of published articles we will take the appropriate steps to correct the scientific record. These may include issuing an expression of concern or retraction of the published article.
We encourage authors to follow the guidelines for good research practice outlined at the following sites.
COPE
Responsible Conduct of Research NIH
National Research Ethics Centre
Authors should follow our journal guidelines for declaring authorship, conflicts of interest, statement of informed consent/privacy and confidentiality, and statement of human and animal rights. Additional areas for concern include, but are not limited to, falsification or distortion of data, failure to provide data post acceptance, duplicate publication, and plagiarism.
GENETICS and G3 do not consider cases of unintentional error to be misconduct. In those cases, where a small portion of the publication contains an honest error, or the author list is incorrect, we will publish a Corrigendum.
Please address any concerns or questions regarding G3 to g3-gsa@thegsajournals.org.
Image Manipulation
Images must not be manipulated in any way that misrepresents the original data. Examples of inappropriate manipulations include:
Selective alteration of specific features or regions within an image, e.g. removing or obscuring bands in a gel photo, or enhancing brightness for a specific cell within a group;
Grouping together images without clearly indicating the edit using dividing lines or some other visual marker, e.g. combining lanes from different gels into a composite image;
Selectively making the image background appear more uniform, e.g. “erasing” background noise;
Duplicating images (e.g. controls) in different figures or parts of a figure without clearly indicating this duplication in the figure legend.
Adjustments to brightness, contrast, and color balance that clarify presentation of the data are acceptable only if they are applied uniformly to the entire image. Non-linear adjustments (such as gamma setting adjustments) should be noted in the text.
If editors suspect any images in your manuscript have been inappropriately manipulated, they may request the original image files for comparison. If original files are not available or reveal inappropriate manipulations, the editors may reject or withdraw acceptance of your manuscript.
Third-Party Permissions
If you wish to reproduce any material for which you do not own the copyright—including quotations, tables, or images—you must obtain permission from the copyright holder. The permissions agreement must include the following documents:
nonexclusive rights to reproduce the material in your article in GENETICS
both print and electronic rights, preferably for use in any form or medium
lifetime rights to use the material
worldwide English-language rights
Please see Copyright and Permissions Guidelines for further information on obtaining permissions.
Data Policy
Availability of Data and Materials
When you publish in G3, you help to catalyze scientific advances by sharing your experimental reagents, results and interpretations. For these articles to have the greatest impact, authors need to make unique research materials and data freely available to other investigators (see Genetics, 184: 1).
G3 requires all authors to publicly release all data and software code underlying any published paper as a condition of publication. Authors are required to include a Data Availability Statement in their article.
Data must be presented in the main manuscript, as supplemental material, or deposited in a public repository. Information on general repositories for all data types, and a list of recommended repositories by subject area, please see Choosing where to archive your data.
For full details on our Data Policy, including Frequently Asked Questions, please see here.
Data Availability Statement
The inclusion of a Data Availability Statement is a requirement for articles published in G3. Data Availability Statements provide a standardized format for readers to understand the availability of data underlying the research results described in the article. The statement may refer to original data generated in the course of the study or to third-party data analyzed in the article. The statement should describe and provide means of access, where possible, by linking to the data or providing the required unique identifier.
The Data Availability Statement should be included in the end matter of your article under the heading “Data availability”.
For more information and example Data Availability Statements, please see Data Availability Statements.
Data Citation
G3 supports the Force 11 Data Citation Principles and requires that all publicly available datasets be fully referenced in the reference list with an accession number or unique identifier such as a digital object identifier (DOI). Data citations should include the minimum information recommended by DataCite:
[dataset]* Authors, Year, Title, Publisher (repository or archive name), Identifier
*The inclusion of the [dataset] tag at the beginning of the citation helps us to correctly identify and tag the citation. This tag will be removed from the citation published in the reference list.
Research Materials
If your manuscript is accepted for publication, you agree to provide any unique research materials at reasonable cost to any investigator who requests them. You are permitted to require that the materials be used only for non-commercial purposes and that the recipient not transfer the materials to a third party without your consent. You may request reasonable payment for costs of sending the material (e.g. shipping and customs fees).
We encourage authors to deposit unique research materials to established repositories. Examples include but are not limited to: Addgene, Drosophila stock centers, C. elegans stock centers, and other stock centers as appropriate.
Examples of unique research materials are strains, plasmids, antibodies (including cell lines producing monoclonal antibodies), and software programs or applications.
Submission
We will consider your manuscript as long as
it is your own original work and does not duplicate any previously published work, including your own;
it is not under consideration, in peer review, or accepted for publication in any journal other than G3;
it has not been published in any other journal; and
it contains nothing abusive, defamatory, libelous, obscene, fraudulent, or illegal.
Authors should observe high ethical standards and obey publication best practices. The following are all unacceptable:
data falsification or fabrication
plagiarism, including duplicate publication of your own work without proper citation
misappropriation of work
We treat any case of ethical or publication malpractice very seriously. We will address them in accordance with the Committee on Publication Ethics (COPE) guidelines. See COPE Guidelines on Good Publication Practice for further information about OUP’s ethical policies.
Review Process
A submitted manuscript is assigned to the Senior Editor of the appropriate subject section. The Senior Editor assigns it to an Associate Editor who manages and adjudicates its review. The Editors will return manuscripts that are judged to be outside the scope of the journal. Manuscripts can be returned without review for reasons that include:
Grammar and style that is not of the quality expected in a published article;
The topic or scope of the work is not within the scope of the journal;
The presentation of the findings is not directed to the readership of the journal;
The methods or approaches are judged to be flawed.
At least two Editorial Board members collaborate in determining whether a manuscript will be returned without review. Manuscripts returned without review may be resubmitted to G3 after suitable revision. Manuscripts sent for review are examined by one or more reviewers selected for their expertise in the subject matter of the article. Reviewers will remain anonymous (unless they choose to reveal themselves). If a paper with findings similar to yours is published while your paper is under review (i.e. if you are "scooped" after submission), your manuscript will not be dismissed from consideration. The Associate Editor makes one of the following decisions on the manuscript:
Accept
Accept pending minor revision
Reconsider upon revision
Reject
The average time from submission until first decision is around 35 days.
How to Submit
You must submit your paper via our web-based submission system, which may be found here https://g3.msubmit.net. If you have not published with G3 before, you will need to create an account. Questions about submitting can be sent to the editorial office at g3-gsa@thegsajournals.org.
Article Types
This journal publishes several different article types.
Investigations
Investigations are full-length research articles with no minimum or maximum length.
Genome Report
Genome Reports enable rapid review and publication of high-quality reports describing whole genome sequence (WGS) data of organisms and/or strains.
The editors of G3 recognize that many WGS datasets describing strain variation, comparative analysis of different model organism species, among other analyses should be made available to the community in an accessible format, even though there may not be substantial new biological insights yet associated with the study. Genome Reports are succinct, and follow guidelines (see below) designed to make it fast and easy for authors to submit, for reviewers to rapidly assess, and for readers to easily understand the report and its results.
Criteria for acceptance in this category includes usefulness of the report (e.g. will the information provided assist future genetic investigations?), quality of the results (e.g. was the WGS well performed?), completeness (e.g. are the results comprehensive?), and the author’s interpretation of results (e.g. are the results of the WGS lucidly interpreted for the reader?). The amount of new information needed to warrant publication as a Genome Report will vary by organism/system; for example, sequencing of a couple of new isolates of Saccharomyces cerevisiae, for which there is substantial information available, would not be considered appropriate while WGS of different mouse strains would more likely fit the criteria for publication. G3 is also interested in transcriptome studies that aid in genome annotation.
A Genome Report submission should have the components listed below; it is acceptable to have additional subheadings or headings as appropriate. We encourage you to be as brief as possible; Genome reports are not meant to be the full length of an Investigation. Authors are referred to the first published Genome Report [Morgan et al. 10.1534/g3.116.034751], as it provides a useful reference.
Title: Include the organism and/or strain names (e.g. Genome Report: Whole genome sequence of two wild-derived Mus musculus domesticus inbred strains, LEWES/EiJ and ZALENDE/EiJ, with different diploid numbers.).
Keywords: Include the relevant organism and strain names.
Abstract: ~250 words. Concise summary of the results.
Introduction: No more than 500 words. The introduction should discuss the rationale for the WGS of the particular organism/strain.
Methods & Materials: Include the following (note: author may write additional subheadings as appropriate – the below points are not designed to be a list of complete subheadings, but rather, topics to be covered).
Organism/Strain origin and derivation
Sequencing methods and preparation details
Data processing methods
Data availability listing where to access all raw reads, processed data, BWTs, and other relevant data. The assembly should be uploaded to NCBI or ENA.
Results and Discussion: Include a description of the genomes, coverage amount of genome sequenced, details of sequence variants ascertained, identifications of deletions, comparison of strains/genomes (if reporting WGS of multiple strains/organisms), and relevance of findings to overall organism/strain catalog.
Data Availability Statement
Acknowledgments
Conflict of Interest
Funder Information
Literature Cited
……
